Collaborate Disseminate
The US National Institutes of Health is investing US$470 million dollars into research on long COVID. The massive nationwide study will include tens of thousands of patients and span more than 30 research institutions.Continue ReadingCategory: Health &… Continue reading US govt to invest half a billion dollars in long COVID research
The results of a major trial testing convalescent plasma therapy for COVID-19 in high-risk outpatients have been published in The New England Journal of Medicine. The once-promising therapy was found to be ineffective in preventing disease progression … Continue reading NIH trial finds blood plasma therapy doesn’t prevent COVID-19 progression
When will COVID-19 vaccine booster shots be necessary? Pfizer has recently claimed a third booster dose of its vaccine may be needed six to 12 months after full vaccination but not everyone is convinced, with new research finding mRNA vaccines could of… Continue reading To boost or not to boost? The big COVID-19 vaccine question
New studies from the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) have concluded SARS-CoV-2, the novel coronavirus responsible for COVID-19, was likely circulating around the United States for several wee… Continue reading CDC and NIH studies find COVID-19 was present in US by December 2019
A clinical trial run by the National Institutes of Health exploring the efficacy of convalescent plasma in treating mild to moderate COVID-19 patients has been halted. The once-promising treatment was deemed unlikely to be of any benefit and follows on… Continue reading US COVID-19 blood plasma trial halted by NIH
A new study examining data from more than three million people suggests reinfection with SARS-CoV-2, the virus that causes COVID-19, is still quite rare. The research affirms a positive antibody test following an initial infection can be associated wit… Continue reading NIH study confirms SARS-CoV-2 reinfections are relatively rare
As close as we’ve gotten to sequencing the entire human genome, there are still a few gaps. But now geneticists have plugged a major one in a landmark new study, by sequencing the entire human X chromosome from end to end, covering more than three mill… Continue reading Human X chromosome completely sequenced for the first time
New research from an international team of scientists has found an old drug, used for over half a century to treat alcoholism, could be repurposed as a useful anti-obesity medication. The animal study saw the drug prevent obesity and improve metabolic … Continue reading Old alcoholism drug shows potential as new anti-obesity treatment
A new article from a quartet of scientific leaders, including Dr. Anthony Fauci, director of National Institute of Allergy and Infectious Diseases (NIAID), is outlining the challenges to overcome in the development of a COVID-19 vaccine over the next o… Continue reading Several COVID-19 vaccines necessary to overcome pandemic, experts say
A new study, funded by the National Institutes of Health’s National Institute on Aging, is offering novel insights into how protein expressions can be altered during the course of Alzheimer’s disease. The research suggests proteins regulating glucose metabolism and the anti-inflammatory activity of brain immune cells are linked with Alzheimer’s pathology, and could point researchers toward new treatment and diagnostics.
Category: Science
Tags: Alzheimer’s Disease, U.S. National Institutes of Health (NIH), Protein, Inflammatory, Glucose, Brain, Neuroscience, New Atlas Audio
Continue reading Discovery links glucose metabolism abnormalities to Alzheimer’s disease